Krystal Biotech, Inc. (KRYS) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress
August 8, 2022 7:00 AM EDTBiologics License Application for B-VEC filed with the FDA on June 22, 2022FDA accepts IND on KB407 for the treatment of Cystic FibrosisStrong balance sheet, closing the quarter with $438.5 million in cash, cash equivalents and investments
PITTSBURGH, Aug. 08, 2022 (GLOBE NEWSWIRE) --... More



